Universal-Beteiligungs- und Servicegesellschaft
DYN icon

Universal-Beteiligungs- und Servicegesellschaft’s Dyne Therapeutics DYN Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$269K Buy
12,111
+310
+3% +$5.76K ﹤0.01% 1958
2026
Q1 		$214K Sell
11,801
-2,598
-18% -$44.8K ﹤0.01% 1973
2025
Q4 		$282K Buy
+14,399
New +$273K ﹤0.01% 1887

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Universal-Beteiligungs- und Servicegesellschaft's DYN Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Dyne Therapeutics (DYN) stake by 2.6% in Q2 2026, buying an estimated $5.76K and bringing the position to 12,111 shares worth $269K. The position accounts for ﹤0.01% of the portfolio, ranked #1958.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in DYN in Q4 2025 and has held it in 3 quarters since. The position peaked at $282K in Q4 2025. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 12,111 shares of Dyne Therapeutics worth $269K as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 310 Dyne Therapeutics shares in Q2 2026, an estimated $5.76K.
  • Dyne Therapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1958 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Dyne Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Dyne Therapeutics position peaked at $282K in Q4 2025.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.